Toxoplasma gondii vaccineAlternative Names: Toxoplasmosis vaccine
Latest Information Update: 17 Jan 2007
At a glance
- Originator GlaxoSmithKline; National Institute of Allergy and Infectious Diseases; National Institutes of Health (USA)
- Class Parasitic vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Toxoplasmosis